Autism risk following antidepressant medication during pregnancy
- PMID: 28528584
- PMCID: PMC6421839
- DOI: 10.1017/S0033291717001301
Autism risk following antidepressant medication during pregnancy
Abstract
Background: Previous studies have examined if maternal antidepressant medication during pregnancy increase the risk of autism spectrum disorder (ASD) in the offspring, but the results have been conflicting.
Methods: In a population-based cohort of 179 007 children born in 2006 and 2007 and followed through 2014 when aged 7 and 8, we estimated relative risks (RRs) of ASD and 95% confidence intervals (CIs) from Cox regression in children exposed to any antidepressant medication during pregnancy, and nine specific antidepressant drugs. Analyses were adjusted for potential confounders and were conducted in the full population sample, and in a clinically relevant sub-sample of mothers with at least one diagnosis of depression or anxiety during life.
Results: The adjusted RR of ASD in children of mothers who used antidepressant medication during pregnancy was estimated at 1.23 (95% CI 0.96-1.57), and at 1.07 (95% CI 0.80-1.43) in women with a history of depression or anxiety. Analyses of specific antidepressants initially revealed increased RRs of offspring ASD confined to citalopram and escitalopram (RR: 1.47; 95% CI 0.92-2.35) and clomipramine (RR: 2.86; 95% CI 1.04-7.82).
Conclusion: Medication with antidepressants during pregnancy does not appear to be causally associated with an increased risk of ASD in the offspring. Instead, the results suggest that the association is explained by factors related to the underlying susceptibility to psychiatric disorders. Based on these findings, the risk of ASD in the offspring should not be a consideration to withhold treatment with commonly used antidepressant drugs from pregnant women.
Keywords: Antidepressant; SSRI.; autism; depression; pregnancy.
Conflict of interest statement
Declaration of Interest
None.
References
-
- Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R (2008). Use of antidepressant medications during pregnancy: a multisite study. American Journal of Obstetrics & Gynecology 198, 194e1–194e5. - PubMed
-
- Bakker MK, Kolling P, van den Berg PB, de Walle HE, de Jong van den Berg LT (2008). Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British Journal of Clinical Pharmacology 65, 600–606. - PMC - PubMed
-
- Boukhris T, Sheehy O, Mottron L, Bérard A (2016).Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatrics 170, 117–124. - PubMed
-
- Castro V, Kong S, Clements C, Brady R, Kaimal A, Doyle A, Robinson E, Churchill S, Kohane I, Perlis R (2016). Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study. Translational Psychiatry 6, e708. - PMC - PubMed
-
- Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R,Watanabe N,Nakagawa A,Omori IM, McGuire H, Tansella M, Barbui C (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373, 746–758. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
